World Investment Advisors reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 11.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,234 shares of the company’s stock after selling 969 shares during the period. World Investment Advisors’ holdings in GE HealthCare Technologies were worth $536,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. N.E.W. Advisory Services LLC purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth $25,000. Bogart Wealth LLC lifted its position in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Olde Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth $35,000. Gladwyn Financial Advisors Inc. purchased a new stake in GE HealthCare Technologies in the second quarter valued at $34,000. Finally, Game Plan Financial Advisors LLC lifted its position in GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
GEHC has been the subject of a number of research reports. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, Wells Fargo & Company reduced their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $86.10.
GE HealthCare Technologies Trading Down 0.1%
NASDAQ GEHC opened at $74.95 on Monday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The firm has a market cap of $34.14 billion, a PE ratio of 15.49, a P/E/G ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The firm’s fifty day moving average is $75.09 and its two-hundred day moving average is $73.14.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
- Five stocks we like better than GE HealthCare Technologies
- Profitably Trade Stocks at 52-Week Highs
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Caterpillar Stock Could Top $650 by Year’s End
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
